BRIEF published on 10/14/2026 at 17:50, 15 days 15 hours ago Eyonis Inc. unveils promising results from eyonis® LCS at CHEST 2026 FDA Artificial Intelligence Lung Cancer Screening Eyonis® LCS CHEST 2026
BRIEF published on 10/14/2026 at 17:50, 15 days 15 hours ago Eyonis Inc. to Showcase AI in Lung Cancer Detection at CHEST 2026 AI In Healthcare Lung Cancer Screening Eyonis® LCS CHEST 2026 FDA-Cleared Technology
BRIEF published on 10/14/2026 at 17:50, 15 days 15 hours ago Eyonis Inc. dévoile les résultats prometteurs d'eyonis® LCS à CHEST 2026 FDA Intelligence Artificielle Eyonis® LCS Dépistage Cancer Poumon CHEST 2026
PRESS RELEASE published on 10/14/2026 at 17:45, 15 days 16 hours ago Inside Information / Other news releases eyonis Inc. to present study results supporting eyonis® LCS performance claims at CHEST 2026. Key insights into AI/ML-based Software as a Medical Device for lung cancer screening. Importance of pulmonologists in adoption Eyonis® LCS CHEST 2026 Eyonis Inc. Pulmonologists AI-enabled Decision Support
PRESS RELEASE published on 10/14/2026 at 17:45, 15 days 16 hours ago Informations privilégiées / Autres communiqués eyonis Inc., filiale de Median Technologies, présentera les performances de eyonis® LCS à CHEST 2026, démontrant une sensibilité de 93,3%, une spécificité de 92,4% et une valeur prédictive négative de 99,9% Median Technologies Eyonis® LCS Dépistage Cancer CHEST 2026 Eyonis Inc.
BRIEF published on 09/15/2026 at 17:50, 1 month 14 days ago Median Technologies Secures Major €8.4 Million iCRO Project AI-powered Solutions Phase III Trial ICRO Project Oncology Imaging Global Pharmaceutical
BRIEF published on 09/15/2026 at 17:50, 1 month 14 days ago Median Technologies décroche un important projet iCRO de 8,4 millions d'euros. Solutions Basées Sur L'IA Essai De Phase III Projet ICRO Imagerie En Oncologie Industrie Pharmaceutique Mondiale
PRESS RELEASE published on 09/15/2026 at 17:45, 1 month 14 days ago Inside Information / Other news releases Median Technologies secures an €8.4 million global phase III oncology imaging project, expanding its iCRO order backlog and revenue visibility. Project awarded by a leading European pharmaceutical company for brain cancer study Pharmaceutical Company Median Technologies Global Project ICRO Oncology Imaging
BRIEF published on 09/08/2026 at 19:50, 1 month 21 days ago Median Technologies: Information on voting rights and capital Share Capital Voting Rights Treasury Shares Financial Market Median Technologies
BRIEF published on 09/08/2026 at 19:50, 1 month 21 days ago Median Technologies' Voting Rights and Capital Structure as of August 2026 Voting Rights Warrants Shares Capital Structure Median Technologies
Published on 10/29/2026 at 22:01, 11 hours 47 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/29/2026 at 21:30, 12 hours 18 minutes ago Shelfie Announces Amendments to Previously Announced Acquisition of Aspect
Published on 10/29/2026 at 18:30, 15 hours 18 minutes ago Kidoz Inc. Appoints Derek Sentner as Chief Revenue Officer
Published on 10/29/2026 at 16:05, 17 hours 43 minutes ago SouthGobi Announces Date of Special Meeting of Shareholders and The Record Date
Published on 10/30/2026 at 09:30, 17 minutes ago HIZENERGY Presents Full‑Range C&I BESS Solutions for European Energy Transition
Published on 10/30/2026 at 09:07, 40 minutes ago Emerald Horizon Chief Scientist Müller: Molten Salt Storage delivers up to six percent more energy
Published on 10/30/2026 at 09:05, 42 minutes ago Baseus Spacemate RD1 Plus: The Definitive 14-in-1 Desk Tower with 4K@120Hz
Published on 10/30/2026 at 09:00, 47 minutes ago Original-Research: MHP Hotel AG (von NuWays AG): BUY
Published on 10/30/2026 at 09:00, 47 minutes ago Original-Research: EBRO MOTORS GROUP EV SA (von NuWays AG): BUY
Published on 10/30/2026 at 08:00, 1 hour 48 minutes ago Neoen secures AUD 1.8 billion in debt financing to support renewable energy portfolio in Australia
Published on 10/30/2026 at 07:00, 2 hours 48 minutes ago Groupe DLSI - Chiffre d'affaires 3ème trimestre 2026
